Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 60,296,824
  • Shares Outstanding, K 1,393,824
  • Annual Sales, $ 9,823 M
  • Annual Income, $ 1,671 M
  • 60-Month Beta 0.78
  • Price/Sales 6.10
  • Price/Cash Flow 19.91
  • Price/Book 6.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.44
  • Number of Estimates 10
  • High Estimate 0.45
  • Low Estimate 0.43
  • Prior Year 0.39
  • Growth Rate Est. (year over year) +12.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.04 +8.72%
on 11/11/19
43.58 -0.11%
on 12/06/19
+2.81 (+6.90%)
since 11/06/19
3-Month
37.65 +15.63%
on 10/10/19
43.65 -0.27%
on 09/24/19
+0.08 (+0.18%)
since 09/06/19
52-Week
31.56 +37.93%
on 12/24/18
43.84 -0.71%
on 09/06/19
+6.76 (+18.38%)
since 12/06/18

Most Recent Stories

More News
Global Peripheral Vascular Devices and Equipment Market Report 2020 Featuring Medtronic, Boston Scientific, Abbott, Cook Group, Angiomed and Medizintechnik - ResearchAndMarkets.com

The "Peripheral Vascular Devices And Equipment Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.

BSX : 43.49 (+0.53%)
MDT : 112.68 (+0.43%)
Boston Scientific's Watchman Implant Study Results Encourage

These study results are expected to be a major breakthrough for Boston Scientific's (BSX) Cardiovascular segment.

BSX : 43.49 (+0.53%)
NUVA : 74.25 (+0.65%)
RMD : 150.96 (+0.52%)
HAE : 122.00 (+1.84%)
BioHybrid Solutions Awarded $30M Contract by the US Dept. of Defense

BioHybrid Solutions, LLC (BHS), a Pittsburgh-based protein engineering company, announced today that it was awarded a contract worth up to $30 million from the United States Department of Defense to develop...

BSX : 43.49 (+0.53%)
AtriCure Names Two Industry Veterans to Board of Directors

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that Karen Prange and Daniel Florin have been...

ATRC : 30.50 (+2.76%)
HSIC : 70.02 (+1.23%)
BSX : 43.49 (+0.53%)
JNJ : 140.79 (+0.88%)
ZBH : 148.63 (+0.68%)
Global Spinal Cord Stimulation (SCS) Market Report 2019-2023 Featuring Profiles of Leading Players Abbott Laboratories, Medtronic, Boston Scientific, and Nevro - ResearchAndMarkets.com

The "Global Spinal Cord Stimulation (SCS) Market: Size, Trends & Forecasts (2019-2023)" report has been added to ResearchAndMarkets.com's offering.

ABT : 85.48 (+0.28%)
BSX : 43.49 (+0.53%)
MDT : 112.68 (+0.43%)
StimGuard Names Executive Management Team to Complete Market Readiness for the World's First Office Based OAB Stimulator System

StimGuard, a privately-held, pre-commercial urology medical device company, today announced the formation of it's executive management team, lead by Laura Tyler Perryman, who has been named CEO and President,...

BSX : 43.49 (+0.53%)
Relatively Good Performance Detected in Shares of Idexx Labs in the Health Care Equipment Industry (IDXX , BSX , ABT , SYK , HOLX )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

ABT : 85.48 (+0.28%)
BSX : 43.49 (+0.53%)
IDXX : 253.07 (+0.48%)
The Netherlands: Advanced Facilities Analysis 2019 - Boston Scientific, Stryker, Astellas, GlaxoSmithKline and Medtronic are the Key Players Operating in the Country - ResearchAndMarkets.com

The "The Netherlands: Advanced Facilities Analysis 2019" report from Wintergreen Research, Inc has been added to ResearchAndMarkets.com's offering.

BSX : 43.49 (+0.53%)
GSK : 45.31 (+0.22%)
Gastro Esophageal Reflux Disease Drug and Devices Market With Moderate CAGR in Forecast Period 2019 to 2026

The research includes a comprehensive analysis of market outlook, methodology and political-economic impacts. The report complies with estimated market size, share, product, revenue, and rate of advancement...

AZN : 47.59 (-0.06%)
BSX : 43.49 (+0.53%)
CEMP : 2.33 (+1.30%)
STIM : 4.61 (+1.54%)
GSK : 45.31 (+0.22%)
IRWD : 12.45 (+0.97%)
MDGS : 1.77 (+0.32%)
MDT : 112.68 (+0.43%)
MRK : 89.04 (+0.33%)
NVS : 92.06 (+0.46%)
PFE : 38.40 (+0.97%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
Boston Scientifc Up 4.8% Since SmarTrend Uptrend Call (BSX)

SmarTrend identified an Uptrend for Boston Scientifc (NYSE:BSX) on October 23rd, 2019 at $40.51. In approximately 4 weeks, Boston Scientifc has returned 4.78% as of today's recent price of $42.44.

BSX : 43.49 (+0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade BSX with:

Business Summary

Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce...

See More

Key Turning Points

2nd Resistance Point 43.92
1st Resistance Point 43.59
Last Price 43.49
1st Support Level 42.75
2nd Support Level 42.24

See More

52-Week High 43.84
Last Price 43.49
Fibonacci 61.8% 39.15
Fibonacci 50% 37.70
Fibonacci 38.2% 36.25
52-Week Low 31.56

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar